Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1988-04-20
1990-01-02
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514182, 540 95, 540 96, 2603175, A61K 3158, A61K 3156, C07J 100, C07J 4300
Patent
active
048913669
ABSTRACT:
2.beta.,16.beta.-diamino-3.alpha.,17.alpha.-oxygenated androstanes having one quaternized group, process for the preparation of these compounds and pharmaceutical compositions comprising such compounds as the active ingredient. The aforementioned compounds are favourable neuro-muscular blocking agents.
REFERENCES:
Tuba, CA 93:72074v (1980).
Cronnelly et al., CA 99:453u (1983).
Carlyle et al, CA 93:155850w (1980).
Buckett et al., CA 79:132827r (1973).
Organon, CA 66:38148e (1967).
CA 106(19): 149492x and Br. J. Pharmacol. 90(3), 511-21, 1987, Gibb et al.
CA 106(13): 96065f and Anaesthesist, 35(11), 661-4, 1986, Gilly et al.
CA 106(11): 78049z and Semin. Anesth. 5(4), 304-11, 1986, Savarese et al.
CA 106(7): 43927g and Anesthesiology, 65(6), 572-8, 1986, A. F. Kopman.
CA 106(7): 43828a and Br. J. Anaesth, 58(11), 1285-9, 1986, Caldwell et al.
CA 106(7): 43405k and Anesth. Analg. (N.Y.), 65(12), 1319-23, 1986m, Meistelman et al.
CA 106(3): 12287u and Anesth. Anal. (N.Y.), 65(3), 245-51, 1986, Bencini et al.
CA 105(23): 202628h and Biomed. Environ. Mass Spectrom 13(7), 327-32, 1986, Castagnoli et al.
CA 104(17): 141740u and Acta. Med. Okayama 39(6), 471-80, 1985, Y. Ohta.
CA 103(23): 189629w and Br. J. Anaesth, 57(8), 782-95, 1985, Bencini et al.
CA 102(3): 2059x and J. Labelled Compd. Radiopharm, 21(5)455-69, 1984, Lehmann et al.
CA 99(15): 115998t and Br. J. Anaesth, 55(8), 703-14, 1983, Marshall et al.
CA 99(1): 455w and Anesthesiology, 58(5), 414-17, 1983, Day et al.
CA 98(8): 6488w and Proc. Int. Symp. Instrum. High Perform Thin Layer Chromatogr. 2nd 186-94, 1982, Ed. R. E. Kaiser.
CA 95(17): 144033x and Anaesthesist, 30(7), 329-33, 1981, Booij et al.
CA 93(5): 36853q and Br. J. Anaesth, 52(3), 313-17, 1980, Salt et al.
CA 92(19): 157540y and J. Pharm. Pharmacol., 31(12), 831-6, 1979, Durant et al.
CA 79(23): 132827r and J. Med. Chem. 16(10) 1116-24, 1973, Buckett et al.
Savage David S.
Sleigh Thomas
Taylor Robert
Akzo N.V.
Blackstone William M.
Lipovsky Joseph A.
Robinson Douglas W.
LandOfFree
Novel 2.beta.,16.beta.-diamino-androstanes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel 2.beta.,16.beta.-diamino-androstanes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel 2.beta.,16.beta.-diamino-androstanes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1383830